Department of Pediatrics

Predicting blood clots before they happen in pediatric patients

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

American Pediatric Association honors two Children’s Hospital pediatricians

Two physicians in Vanderbilt’s Department of Pediatrics — James Antoon, MD, PhD, and Shani Jones, MD — have been honored for their work by the American Pediatric Association.

New clue to lung scarring

Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases.

Goode, Hine receive 2021 Geoffrey David Chazen Faculty Award for Innovation in Medical Education

Rachel Goode, MD, and Jeffrey Hine, MD, are the recipients of the 2021 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

Study seeks to increase volume-targeted ventilation use

For more than two decades, evidence has accrued that the use of volume-targeted ventilation (VTV) results in better outcomes in neonates who require mechanical ventilation in the Neonatal Intensive Care Unit (NICU).

1 23 24 25 26 27 56